Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reneuron Group Plc.

0.0011
0.0000
Volume:- -
Turnover:- -
Market Cap:62.89K
PE:-0.01
High:0.0011
Open:0.0011
Low:0.0011
Close:0.0011
Loading ...

Company Profile

Company Name:
Reneuron Group Plc.
Exchange:
EXPERT
Establishment Date:
1997
Employees:
26
Office Location:
Pencoed Business Park,Pencoed,Mid Glamorgan,United Kingdom
Zip Code:
CF35 5HY
Fax:
- -
Introduction:
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.